Latest On Siemens Healthineers AG (SEMHF):
| Date/Time | Type | Description | Signal | Details |
|---|---|---|---|---|
| 2024-04-19 05:57 EST | Dividend | A dividend of $0.95 has been announced on Nov 7, 2023. It will be paid Apr 23, 2024 with an ex-dividend date of Apr 19, 2024. | Neutral |  |
| 2023-05-29 17:23 EST | News | Siemens Healthineers: Still A Company Worth Looking At | N/A | |
| 2023-05-10 22:48 EST | News | Siemens Healthineers AG Non-GAAP EPS of €0.43, revenue of €5.35B | N/A | |
| 2023-02-16 04:56 EST | Dividend | A dividend of $0.95 has been announced on Dec 16, 2022. It will be paid Feb 20, 2023 with an ex-dividend date of Feb 16, 2023. | Neutral | |
| 2023-02-02 11:45 EST | News | Siemens Healthineers AG Non-GAAP EPS of €0.47, revenue of €5.07B | N/A | |
| 2022-11-17 13:09 EST | News | Siemens Non-GAAP EPS of €3.59, revenue of €20.57B | N/A | |
| 2022-11-09 15:45 EST | News | Siemens Healthineers AG Non-GAAP EPS of €0.65, revenue of €6B beats by €230M | N/A | |
| 2022-08-03 13:37 EST | News | Siemens Healthineers AG Non-GAAP EPS of €0.43, revenue of €5.19B | N/A | |
| 2022-05-04 16:04 EST | News | Siemens Healthineers AG Non-GAAP EPS of $0.67, revenue of $5.46B misses by $20M | N/A | |
| 2022-02-16 04:57 EST | Dividend | A dividend of $0.85 has been announced on Dec 20, 2021. It will be paid Feb 18, 2022 with an ex-dividend date of Feb 16, 2022. | Neutral | |
| 2022-02-03 20:42 EST | News | Siemens Healthineers AG Non-GAAP EPS of €0.55, revenue of €5.07B | N/A | |
| 2021-11-04 19:59 EST | News | Siemens Healthineers AG reports Q4 results | N/A | |
| 2021-07-31 00:29 EST | News | Siemens Healthineers AG misses on revenue | N/A | |
| 2021-04-08 00:50 EST | News | Siemens Healthineers wins Chinese antitrust approval for Varian Medical deal | N/A | |
| 2021-02-19 19:21 EST | News | Siemens Healthineers wins conditional EU approval for Varian Medical deal | N/A | |
| 2021-02-16 01:33 EST | News | EU close to approving Siemens Healthineers $16b Varian acquisition | N/A | |
| 2021-02-12 04:59 EST | Dividend | A dividend of $0.8 has been announced on Nov 6, 2020. It will be paid Feb 17, 2021 with an ex-dividend date of Feb 12, 2021. | Neutral | |
| 2021-02-10 08:51 EST | Financials | Company financials have been released. | Neutral | |
| 2021-02-01 23:45 EST | News | Siemens Healthineers AG reports Q1 results | N/A | |
| 2021-02-01 23:45 EST | News | European Commission review of Varian/Siemens Healthineers deal extended | N/A | |
| 2020-12-21 00:29 EST | News | Siemens Healthineers: A Rising Star | N/A | |
| 2020-11-26 22:20 EST | Financials | Company financials have been released. | Neutral | |
| 2020-11-09 14:06 EST | Financials | Company financials have been released. | Neutral | |
| 2020-11-08 01:30 EST | Financials | Company financials have been released. | Neutral | |
| 2020-11-07 17:47 EST | Financials | Company financials have been released. | Neutral | |
| 2020-11-02 08:55 EST | News | Siemens Healthineers AG reports FQ4 results | N/A | |
| 2020-09-26 14:47 EST | Financials | Company financials have been released. | Neutral | |
| 2020-09-17 06:51 EST | Financials | Company financials have been released. | Neutral | |
| 2020-08-31 07:21 EST | Financials | Company financials have been released. | Neutral | |
| 2020-08-14 10:47 EST | Financials | Company financials have been released. | Neutral | |
| 2020-08-07 06:10 EST | Financials | Company financials have been released. | Neutral | |
| 2020-08-06 10:08 EST | Financials | Company financials have been released. | Neutral | |
| 2020-08-04 01:46 EST | News | Siemens Healthineers AG reports Q3 results | N/A | |
| 2020-08-03 02:53 EST | News | Varian to get bought in $16B deal by Siemens Healthineers | N/A | |
| 2020-08-02 05:45 EST | News | Siemens Healthineers near $15B deal for Varian - Bloomberg | N/A | |
| 2020-07-30 18:32 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-30 06:29 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-29 22:40 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-27 14:23 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-23 19:08 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-09 10:36 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-01 18:22 EST | Financials | Company financials have been released. | Neutral | |
| 2020-06-19 14:15 EST | Financials | Company financials have been released. | Neutral | |
| 2020-06-14 06:19 EST | Financials | Company financials have been released. | Neutral | |
| 2020-06-12 07:53 EST | Financials | Company financials have been released. | Neutral | |
| 2020-05-27 23:28 EST | News | Siemens Healthineers: Excellent Company, But The Valuation Doesn't Scan | N/A | |
| 2020-05-27 06:56 EST | Financials | Company financials have been released. | Neutral | |
| 2020-05-22 22:09 EST | Financials | Company financials have been released. | Neutral | |
| 2020-05-21 02:29 EST | Financials | Company financials have been released. | Neutral | |
| 2020-05-10 05:12 EST | News | Siemens Healthineers AG (SEMHF) CEO Bernd Montag on Q2 2020 Results - Earnings Call Transcript | N/A | |
About Siemens Healthineers AG (SEMHF):
Siemens Healthineers AG, through its subsidiaries, develops, manufactures, and distributes imaging, diagnostic, and advanced therapies products and services to healthcare providers worldwide. The company operates through three segments; Imaging, Diagnostics, and Advanced Therapies. The Imaging segment offers magnetic resonance, computed tomography, X-ray, molecular imaging, and ultrasound systems. The Diagnostics segment provides in-vitro diagnostic products and services to healthcare providers in laboratory, molecular, and point-of-care diagnostics; and workflow solutions and informatics products. The Advanced Therapies segment offers integrated products, solutions, and services for therapy departments of healthcare providers; and robotic-assisted platform for endo-vascular coronary and peripheral vascular interventions. This segment's principal products include angiography systems and mobile C-arms. It also provides customer value chain services, including design, maintenance, operational management, training, and education services. In addition, the company offers equipment performance management, clinical education and e-learning, asset management, and managed departmental services, as well as digital health products and services. The company is headquartered in Erlangen, Germany. Siemens Healthineers AG operates as a subsidiary of Siemens Aktiengesellschaft.
General
- Name Siemens Healthineers AG
- Symbol SEMHF
- Type Common Stock
- Exchange OTCGREY
- Currency USD
- Country USA
- Full Time Employees 54,500
- Fiscal Year EndSeptember
- Web URLhttp://www.siemens-healthineers.com
Valuation
- Trailing PE 38.08
Financials
- Most Recent Quarter 2020-12-31
- Profit Margin 10%
- Return on Assets 6%
- Return on Equity 14%
- Earnings Per Share $1.47
- Revenue Per Share $0
- Gross Profit 5.58 billion
- Quarterly Earnings Growth 7.8%
Highlights
- Market Capitalization 55.22 billion
- Book Value Per Share $10.09
Share Statistics
- Shares Outstanding 999.75 million
- Shares Float 222.08 million
- % Held by Insiders 7907%
- % Held by Institutions 6.08%
Technicals
- Beta 0.47
- 52 Week High $60.25
- 52 Week Low $36.5
- 50 Day Moving Average 54.81
- 200 Day Moving Average 47.92
Dividends
- Dividend Date N/A
- ExDividend Date N/A
- Dividend Per Share $0.82
- Dividend Yield 0%
Siemens Healthineers AG (SEMHF) Dividend Calendar:
| Ex-Dividend Date | Payment Date | Record Date | Declared Date | Amount |
|---|
Siemens Healthineers AG (SEMHF) Earnings History:
Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.
| Quarter Date | Report Date | Actual Revenue | Reported EPS | EPS Estimate | Deviation from Estimate |
|---|---|---|---|---|---|
| 2020-09-30 | 2020-12-31 | $N/A | $0.49 | $0.00 | |
| 2020-06-30 | 2020-09-30 | $N/A | $0.49 | $0.27 | 80.56% |
| 2020-03-31 | 2020-06-30 | $N/A | $0.30 | $0.40 | -24.15% |
| 2019-12-31 | 2020-03-31 | $3.59 billion | $0.45 | $0.39 | 15.87% |
| 2019-09-30 | 2019-12-31 | $4.14 billion | $0.34 | $0.50 | -32.7% |
| 2019-06-30 | 2019-09-30 | $3.57 billion | $0.54 | $0.36 | 50.33% |
| 2019-03-31 | 2019-06-30 | $3.51 billion | $0.40 | $0.40 | -0.5% |
| 2018-12-31 | 2019-03-31 | $3.3 billion | $0.43 | $0.37 | 15.3% |
| 2018-09-30 | 2018-12-31 | $3.7 billion | $0.39 | $0.46 | -15.33% |
| 2018-06-30 | 2018-09-30 | $2.5 billion | $0.42 | $0.37 | 12.65% |
| 2018-03-31 | 2018-06-30 | $3.23 billion | $0.34 | $0.36 | -5.94% |
| 2017-12-31 | 2018-03-31 | $3.2 billion | $0.37 | $0.00 | |
| 2017-09-30 | 2017-12-31 | $0.37 | $0.00 | ||
| 2017-06-30 | 2017-09-30 | $3.31 billion | $0.47 | $0.00 | |
| 2017-03-31 | 2017-06-30 | $3.4 billion | $0.37 | $0.00 | |
| 2016-12-31 | 2017-03-31 | $3.33 billion | $0.32 | $0.00 | |
| 2016-09-30 | 2016-12-31 | $0.35 | $0.00 |
Siemens Healthineers AG (SEMHF) Company Financial Statements:
Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.
Income Statement:
| Date | Dec 31 2020 | Sep 30 2020 | Jun 30 2020 | Apr 30 2020 | Mar 31 2020 |
|---|---|---|---|---|---|
| Research Development | N/A | N/A | N/A | N/A | N/A |
| Income Before Tax | N/A | N/A | N/A | N/A | N/A |
| Selling General Administrative | N/A | N/A | N/A | N/A | N/A |
| Gross Profit | N/A | N/A | N/A | N/A | N/A |
| Ebit | N/A | N/A | N/A | N/A | N/A |
| Operating Income | N/A | N/A | N/A | N/A | N/A |
| Income Tax Expense | 169 million | 118 million | 131 million | 131 million | 168 million |
| Total Revenue | N/A | N/A | N/A | N/A | N/A |
| Cost of Revenue | N/A | N/A | N/A | N/A | N/A |
| Total Other Income Expense Net | N/A | N/A | N/A | N/A | N/A |
| Net Income From Continuing Operations | N/A | N/A | N/A | N/A | N/A |
| Net Income Applicable to Common Shares | 432 million | 428 million | 270 million | 270 million | 411 million |
Cash Flow:
| Date | Sep 30 2020 | Jun 30 2020 | Apr 30 2020 | Mar 31 2020 | Jan 31 2020 |
|---|---|---|---|---|---|
| Investments | N/A | N/A | N/A | N/A | N/A |
| Change to Liabilities | 43 million | 24 million | 24 million | 83 million | 83 million |
| Total Cash Flow from Investing Activities | -176 million | -139 million | -139 million | -143 million | -143 million |
| Net Borrowings | -58 million | -28 million | -28 million | -13 million | -13 million |
| Total Cash Flow from Financial Activities | N/A | N/A | N/A | N/A | N/A |
| Change to Operating Activities | 214 million | 38 million | 38 million | -203 million | -203 million |
| Change in Cash | N/A | N/A | N/A | N/A | N/A |
| Total Cash from Operating Activities | 884 million | 471 million | 471 million | 213 million | 213 million |
| Depreciation | N/A | N/A | N/A | N/A | N/A |
| Other Cash Flow from Investing Activities | N/A | -1000000 | -1000000 | N/A | -1000000 |
| Change to Inventory | N/A | N/A | N/A | N/A | N/A |
| Change to Account Receivables | N/A | N/A | N/A | N/A | N/A |
| Other Cash Flow from Financing Activities | -3.31 billion | -522 million | -522 million | 675 million | 675 million |
| Change to Net Income | -41 million | -27 million | -27 million | 15 million | 15 million |
| Capital Expenditures | N/A | N/A | N/A | N/A | N/A |
Balance Sheet:
| Date | Dec 31 2020 | Sep 30 2020 | Jun 30 2020 | Apr 30 2020 | Mar 31 2020 |
|---|---|---|---|---|---|
| Total Liabailities | N/A | N/A | N/A | N/A | N/A |
| Total Stockholder Equity | N/A | N/A | N/A | N/A | N/A |
| Other Current Liabilities | 6.47 billion | 5.77 billion | N/A | N/A | N/A |
| Total Assets | N/A | N/A | N/A | N/A | N/A |
| Common Stock | 1.08 billion | 1.08 billion | 1000 million | N/A | 1000 million |
| Other Current Assets | 326 million | 339 million | N/A | 1000 million | N/A |
| Retained Earnings | -876 million | -1.28 billion | -1.71 billion | -1.71 billion | -1.99 billion |
| Other Liabilities | 4.86 billion | 4.98 billion | 1.96 billion | 1.96 billion | 2.05 billion |
| Other Assets | 765 million | 713 million | 637 million | 637 million | 598 million |
| Cash | N/A | N/A | N/A | N/A | N/A |
| Total Current Liabilities | 8.05 billion | 7.29 billion | N/A | N/A | N/A |
| Other Stockholder Equity | 12.14 billion | 12.7 billion | 10.43 billion | 10.43 billion | 10.66 billion |
| Property, Plant & Equipment | 2.77 billion | 2.77 billion | 2.76 billion | 2.76 billion | 2.71 billion |
| Total Current Assets | 10.92 billion | 10.27 billion | N/A | N/A | N/A |
| Long Term Investments | N/A | N/A | N/A | N/A | N/A |
| Net Tangible Assets | 1.57 billion | 1.55 billion | -1.55 billion | -1.55 billion | -1.88 billion |
| Short Term Investments | N/A | N/A | N/A | N/A | N/A |
| Long Term Debt | N/A | N/A | N/A | N/A | N/A |
| Inventory | 2.38 billion | 2.3 billion | N/A | N/A | N/A |
| Accounts Payable | 1.35 billion | 1.36 billion | N/A | N/A | N/A |
Siemens Healthineers AG (SEMHF) Chart:
Siemens Healthineers AG (SEMHF) News:
Below you will find a list of latest news for Siemens Healthineers AG (SEMHF) from major news sources. You can filter the results to only show news from a specific source.
No recent news available
Siemens Healthineers AG (SEMHF) Options:
A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.
| Expiration Date | Strike | Last Price | Type | Volume | Open Interest | Implied Volatility | In The Money | Change | Change Percent |
|---|
Siemens Healthineers AG (SEMHF) SEC Filings:
An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.
| Date | Form Type | Form Name | Link |
|---|